Literature DB >> 8455363

Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.

M G Betjes1, C W Tuk, D G Struijk, R T Krediet, L Arisz, E C Hoefsmit, R H Beelen.   

Abstract

Peritoneal cells (PC) from 75 patients were immuno-phenotypically and functionally characterized during the first year of CAPD treatment (PCcapd) and compared to PC obtained by laparoscopy of healthy women (control peritoneal cells). Patients were divided, according to their peritonitis incidence (PI), into a high PI (HPI) and a low PI group (LPI). The yield of PCcapd decreased significantly over the year. The differential cell count and immunophenotype of PCcapd remained unchanged in the LPI group, but the percentage of macrophages decreased over the year in the HPI group. Macrophages in the PCcapd, when compared to control peritoneal cells, had a less mature phenotype as measured by RFD7 expression but a higher Fc-receptor expression. The PCcapd showed a higher percentage of B cells, CD4 positive T cells and activated T cells bearing HLA-DR/DQ when compared to the control peritoneal cells. Over the year a decrease in chemotactic activity of the PCcapd towards 10(-8) M N-formylmethionyl-leucyl-phenylalanine and dialysis effluent was observed in LPI patients but not in HPI patients. After one year of treatment, a significantly higher percentage of phagocytosing macrophages in the PCcapd of HPI patients was found when compared to LPI patients. During the year there was an increase of immunophagocytosis of PCcapd independent of PI. In conclusion, the CAPD peritoneal cellular immune system showed signs of both immaturity and activation. The decrease in the yield and in the chemotactic activity of PCcapd suggests an adaptation to the chronic stimulus of the dialysis fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455363     DOI: 10.1038/ki.1993.93

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Peritoneal Dialysis Catheter Increases Leukocyte Recruitment in the Mouse Parietal Peritoneum Microcirculation and Causes Fibrosis.

Authors:  Paulina M Kowalewska; Peter J Margetts; Alison E Fox-Robichaud
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

2.  Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.

Authors:  A Brauner; Y Lu; G Halldén; B Hylander; J Lundahl
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

3.  Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis.

Authors:  M L McCully; T A Chau; P Luke; P G Blake; J Madrenas
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.

Authors:  Caatje Y le Poole; Angelique G A Welten; Piet M ter Wee; Nanne J Paauw; Amina N Djorai; Rob M Valentijn; Robert H J Beelen; Jacob van den Born; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

5.  IgG and complement receptor expression in children treated by peritoneal dialysis.

Authors:  Antonia H M Bouts; Jean-Claude Davin; Raymond T Krediet; Cornelis H Schröder; Leo A H Monnens; Jeroen Nauta; Jan G J van de Winkel; Theo A Out
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

6.  Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci.

Authors:  C E Visser; J J Steenbergen; M G Betjes; S Meijer; L Arisz; E C Hoefsmit; R T Krediet; R H Beelen
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis.

Authors:  M G Betjes; C W Tuk; D G Struijk; R T Krediet; L Arisz; R H Beelen
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

Review 8.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis.

Authors:  Y C Ko; N Mukaida; T Kasahara; S Muto; K Matsushima; E Kusano; Y Asano; Y Itoh; Y Yamagishi; T Kawai
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.